BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 16, 2005
View Archived Issues
GAD: Spotlight on patients that "worry themselves sick"
Read More
Roche profiles successful quarter
Read More
Recordati licenses Stanate from InfaCare
Read More
Cardio Vascu-Grow shows preclinical potential for peripheral vascular disease
Read More
Enzo acquires rights to drug candidate for treating uveitis
Read More
Trimeris, ChemBridge Research Laboratories to develop HIV entry inhibitors
Read More
Orphan drug designation for Vical's CMV DNA vaccine
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Profiling of recombinant human IGF-1 treatment
Read More
New therapeutics claimed for diabetes
Read More
Gallium maltolate demonstrates in vivo efficacy for RA
Read More
Mechanisms underlying new apoptosis-inducing agents developed by Maxim
Read More
Recent patents reveal new agents for hepatitis treatment
Read More
Cinacalcet reported effective in hyperparathyroidism after renal transplantation
Read More
Update on everolimus in the prevention of allograft rejection
Read More
Hematological changes reported for CC-4047 in multiple myeloma patients
Read More
Promising results found for inolimumab in steroid-resistant aGvHD
Read More
Scios convenes panel of cardiology experts to review Natrecor
Read More
Miraxion enters phase III trial for Huntington's disease
Read More
Exelixis submits IND for XL-184
Read More
Medarex and Boehringer Ingelheim enter antibody development agreement
Read More
Metabolic receives grant for phase I trial of ACV-1 for neuropathic pain
Read More
Expanded access program planned for protease inhibitor TMC-114
Read More
Indiplon capsules NDA accepted for review
Read More
Merck KGaA wins patent appeal
Read More
NDS filed for Abraxane in Canada
Read More
Mylan plans to outlicense nebivolol
Read More